This symposium will deliver an up to date overview of the latest advances in the management of neuroblastoma, sarcoma and brain tumors, including emerging modalities such as proton therapy, immunotherapy, and CAR T cell therapy.

A distinguished faculty of leading experts from nationally recognized cancer centers — including Dana-Farber, MSKCC, UCLA, and UNC — will present cutting edge technologies and evidence based therapeutic strategies for addressing complex clinical challenges.

In a shared commitment to providing the highest level of care to the communities they serve, two of South Florida’s leading healthcare institutions — Herbert Wertheim Cancer Institute, part of Baptist Health South Florida, the region’s largest not for profit healthcare provider, and Nicklaus Children’s Hospital, part of Miami Children’s Health System and the area’s premier provider of pediatric healthcare — have partnered to advance healthcare through continuing education.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more accreditation information, and registration details, please visit the Baptist Health Continuing Medical Education website.